Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study

Vera E. R. Asscher*, Vince B. C. Biemans, Marieke J. Pierik, Gerard Dijkstra, Mark Lowenberg, Sander van der Marel, Nanne K. H. de Boer, Alexander G. L. Bodelier, Jeroen M. Jansen, Rachel L. West, Jeoffrey J. L. Haans, Willemijn A. van Dop, Rinse K. Weersma, Frank Hoentjen, P. W. Jeroen Maljaars, Dutch Initiative Crohn and Colitis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1366-1376
Number of pages11
JournalAlimentary Pharmacology & Therapeutics
Volume52
Issue number8
DOIs
Publication statusPublished - Oct 2020

Keywords

  • MAINTENANCE THERAPY
  • ELDERLY-PATIENTS
  • INDUCTION
  • RISK

Cite this